SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 18 filers reported holding SOLENO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,000 | -98.7% | 12,612 | -98.1% | 0.01% | -99.2% |
| Q4 2020 | $1,279,000 | +22.4% | 662,612 | +59.1% | 1.06% | -1.5% |
| Q3 2020 | $1,045,000 | +28.5% | 416,432 | +13.6% | 1.07% | +21.7% |
| Q2 2020 | $813,000 | -23.4% | 366,432 | -17.9% | 0.88% | -53.8% |
| Q1 2020 | $1,062,000 | -19.1% | 446,232 | 0.0% | 1.90% | -13.3% |
| Q4 2019 | $1,312,000 | +194.2% | 446,232 | +50.2% | 2.20% | +391.5% |
| Q3 2019 | $446,000 | -40.5% | 297,132 | +10.9% | 0.45% | -56.0% |
| Q2 2019 | $750,000 | +51.2% | 268,000 | +11.4% | 1.02% | +7.5% |
| Q1 2019 | $496,000 | +71.0% | 240,645 | +42.1% | 0.94% | +44.3% |
| Q4 2018 | $290,000 | -12.1% | 169,380 | +10.8% | 0.66% | +37.3% |
| Q3 2018 | $330,000 | +9.3% | 152,829 | +18.2% | 0.48% | +7.2% |
| Q2 2018 | $302,000 | – | 129,243 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $22,769,000 | 6.37% |
| CVI Holdings, LLC | 1,550,960 | $3,443,000 | 1.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,670,384 | $8,148,000 | 1.03% |
| Trellus Management Company, LLC | 366,432 | $813,000 | 0.88% |
| AWM Investment Company, Inc. | 1,550,000 | $3,441,000 | 0.60% |
| Samsara BioCapital, LLC | 750,000 | $1,665,000 | 0.54% |
| Nantahala Capital Management | 7,426,368 | $16,487,000 | 0.50% |
| Consonance Capital Management LP | 3,040,000 | $6,749,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,233,676 | $2,739,000 | 0.26% |
| Granite Point Capital Management, L.P. | 2,200,000 | $4,884,000 | 0.25% |